Cargando…

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia

Schizophrenia is a complex psychiatric disorder strongly associated with substance use disorders. Theoretically, schizophrenia and SUD may share endocannabinoid alterations in the brain reward system. The main endocannabinoids, anandamide, and 2-arachidonoylglycerol, are lipids which bind cannabinoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desfossés, Joëlle, Stip, Emmanuel, Bentaleb, Lahcen Ait, Lipp, Olivier, Chiasson, Jean-Pierre, Furtos, Alexandra, Venne, Karine, Kouassi, Edouard, Potvin, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/ https://www.ncbi.nlm.nih.gov/pubmed/23055987 http://dx.doi.org/10.3389/fpsyt.2012.00085

Ejemplares similares

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case–Control Trial with Quetiapine
por: Zhornitsky, Simon, et al.
Publicado: (2011)

Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images
por: Potvin, Stéphane, et al.
Publicado: (2017)

Relationships between Brain Structure and Metabolic Changes in Schizophrenia Patients Treated with Olanzapine: A Voxel-Based Morphometric Study
por: Letourneau, Genevieve, et al.
Publicado: (2011)

Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting
por: Potvin, Stéphane, et al.
Publicado: (2020)

Modulation of the Endocannabinoid System: Vulnerability Factor and New Treatment Target for Stimulant Addiction
por: Olière, Stéphanie, et al.
Publicado: (2013)

Agenesis of Corpus Callosum and Emotional Information Processing in Schizophrenia
por: Lungu, Ovidiu, et al.
Publicado: (2012)

Violent Behavior Is Associated With Emotion Salience Network Dysconnectivity in Schizophrenia
por: Tikàsz, Andràs, et al.
Publicado: (2020)

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
por: Chye, Yann, et al.
Publicado: (2019)

The Neural Correlates of Mental Rotation Abilities in Cannabis-Abusing Patients with Schizophrenia: An fMRI Study
por: Potvin, Stéphane, et al.
Publicado: (2013)

Emotionally Neutral Stimuli Are Not Neutral in Schizophrenia: A Mini Review of Functional Neuroimaging Studies
por: Potvin, Stéphane, et al.
Publicado: (2016)

From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia
por: Hoffman, Kurt Leroy
Publicado: (2021)

The mirror mechanism in schizophrenia: A systematic review and qualitative meta-analysis
por: Valizadeh, Amir, et al.
Publicado: (2022)

Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis
por: Zhornitsky, Simon, et al.
Publicado: (2015)

Avatar Therapy for Persistent Auditory Verbal Hallucinations in an Ultra-Resistant Schizophrenia Patient: A Case Report
por: Dellazizzo, Laura, et al.
Publicado: (2018)

Dropout Rates in Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse: A Systematic Review and Meta-Analysis
por: Bouchard, Marianne, et al.
Publicado: (2022)

Genealogy of Instruments for Prodrome Evaluation of Psychosis
por: Daneault, Jean-Gabriel, et al.
Publicado: (2013)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020)

Endocannabinoids and Precision Medicine for Mood Disorders and Suicide
por: Pinna, Graziano
Publicado: (2021)

Persistency of Cannabis Use Predicts Violence following Acute Psychiatric Discharge
por: Dugré, Jules R., et al.
Publicado: (2017)

Bibliotherapy: Reading OVID During COVID
por: Stip, Emmanuel, et al.
Publicado: (2020)

Metaphor Processing Dysfunctions in Schizophrenia Patients With and Without Substance Use Disorders
por: Karabanowicz, Ewa, et al.
Publicado: (2020)

Markedly Reduced Thermal Pain Perception in a Schizoaffective Patient with Tardive Dyskinesia
por: Potvin, Stéphane, et al.
Publicado: (2016)

Trajectories of Dynamic Risk Factors as Predictors of Violence and Criminality in Patients Discharged From Mental Health Services: A Longitudinal Study Using Growth Mixture Modeling
por: Beaudoin, Mélissa, et al.
Publicado: (2019)

Patterns of Substance Abuse in Offenders With Schizophrenia— Illness-Related or Criminal Life-Style?
por: Stompe, Thomas, et al.
Publicado: (2018)

Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive Dysfunction
por: Rodriguez Cruz, Jose, et al.
Publicado: (2021)

Progesterone and Cerebral Function during Emotion Processing in Men and Women with Schizophrenia
por: Champagne, Julie, et al.
Publicado: (2012)

The Psychometric Properties of a Short UPPS-P Impulsive Behavior Scale Among Psychiatric Patients Evaluated in an Emergency Setting
por: Dugré, Jules Roger, et al.
Publicado: (2019)

Endocannabinoid System Unlocks the Puzzle of Autism Treatment via Microglia
por: Su, Tangfeng, et al.
Publicado: (2021)

Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy
por: Epps, S. Alisha
Publicado: (2022)

Internet Addiction, Hikikomori Syndrome, and the Prodromal Phase of Psychosis
por: Stip, Emmanuel, et al.
Publicado: (2016)

Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment
por: Stip, E, et al.
Publicado: (2012)

Editorial: Novel Approaches to Improve Detection, Differentiation and Treatment in Mood Disorders
por: Abdel Aziz, Karim, et al.
Publicado: (2022)

Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry
por: De Gregorio, Danilo, et al.
Publicado: (2021)

Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs
por: Bourque, Josiane, et al.
Publicado: (2021)

Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review
por: Johnstone, Samantha, et al.
Publicado: (2022)

Avatar Intervention for Cannabis Use Disorder in Individuals with Severe Mental Disorders: A Pilot Study
por: Giguère, Sabrina, et al.
Publicado: (2023)

The origins of evil: From lesions to the functional architecture of the antisocial brain
por: Dugré, Jules R., et al.
Publicado: (2022)

FAAH and CNR1 Polymorphisms in the Endocannabinoid System and Alcohol-Related Sleep Quality
por: Soundararajan, Soundarya, et al.
Publicado: (2021)

The Endocannabinoid System across Postnatal Development in Transmembrane Domain Neuregulin 1 Mutant Mice
por: Chesworth, Rose, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t8k14vbmbcpq672epes5b6tnf1